Steven Weiner
Santa Rosa Beach, FLNPI 1770949893
Payments from drug & device makers
$752,319in general payments, 2019–2025
Across 717 payments — averaging $1049.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$686K
- Clarius Mobile Health Corp.$23K
- Merz North America, Inc.$20K
- AbbVie$17K
- Lumenis, Inc$4K
- Revance Therapeutics, Inc.$688
- plus $616 from 5 others
What the payments were for
- Consulting fees$143,92621%
- Speaking & faculty fees$470,46469%
- Travel & lodging$51,2368%
- Food & beverage$14,2932%
General payments by program year
19
20
21
22
23
24
25
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 642 | $686,347 |
| Clarius Mobile Health Corp. | 4 | $23,250 |
| Merz North America, Inc. | 16 | $20,086 |
| AbbVie(2 entities) | 41 | $17,010 |
| Lumenis, Inc | 1 | $4,322 |
| Revance Therapeutics, Inc. | 8 | $688 |
| Fujifilm Sonosite, Inc. | 1 | $375 |
| Zimmer Biomet | 1 | $123 |
| Apyx Medical Corporation | 1 | $70 |
| Bausch Health US, LLC | 1 | $25 |
| TELA Bio, Inc. | 1 | $23 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.